Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
Conclusion[99mTc]Tc-N4-BTG appears to be a safe diagnostic agent. Compared to GRPR-targeted PET tracers, this99mTc-labelled SPECT agent could contribute to a broader application and better availability of this novel approach. Further research to assess its clinical value is warranted.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | CT Scan | Gastroenterology | Liver | Pancreas | Pancreatic Cancer | Prostate Cancer | Radiology | SPECT | Study | Urology & Nephrology